Wednesday, June 2, 2021 Daily Archives

Dyadic: For COVID-19 vaccines, ‘we have what the world needs’

by

The industry needs to rethink COVID-19 vaccine production according to Dyadic, which says its fungus-based expression system could supply the world at a lower cost than current mRNA offerings. As the global COVID-19 vaccine rollout continues and companies like Moderna and Pfizer become household names, Dyadic CEO Mark Emalfarb told BioProcess Insider its C-1 cell protein production platform could potentially produce “antigens, quicker, faster, and in larger volumes at a lower cost.†He continued: “We could have seeded the world…

June 2, 2021

Avantor boosts single-use production with RIM buy

by

Avantor has added a manufacturing plant in Changzhou, China through the acquisition of single-use bag and system producer RIM Bio. The acquisition – financials of which have not been divulged – brings Avantor a facility in China that produces single-use systems including 2D bags, 3D bags, tank liners, bag assemblies and multi-bag manifolds used in the manufacturing of biologics, vaccines, and advanced therapies. Avantor said the addition of its first Asian single-use facility will help boost its global capabilities and capacity…

June 2, 2021

Moderna further expands CDMO partnerships to support COVID vaccine

by

A triumvirate of CDMO expansions will increase production of Moderna’s COVID-19 vaccine: Lonza will repurpose a suite at a Dutch facility to up drug substance, and Aldevron will increase plasmid DNA supply. Meanwhile, Thermo Fisher will provide fill/finish capacity from North Carolina, as will Samsung Biologics from korea. Last month, Moderna announced plans to increase both internal and third-party production of its mRNA COVID-19 vaccine, currently being rolled out under an FDA Emergency Use Authorization (EUA). This included making an…

June 2, 2021